Bucaya, Lito M.
HRN: 23-11-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/02/2024
03/09/2024
IV
500mg
Every 8 Hours
Abdominal Mass ETBD; T/C UGIB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes